Four details:
1. Teladoc and Livongo closed the $18.5 billion deal in just under three months; the telehealth company announced the transaction Aug. 5.
2. Under the merger, Livongo shares will be exchanged for 0.5920 shares of Teladoc plus cash of $11.33 each consideration per share.
3. The transaction is valued at $18.5 billion based on Teladoc’s closing price Aug. 4.
4. On Oct. 15, Teladoc CEO Jason Gorevic filed a letter with the Securities and Exchange Commission stating that four of Livongo’s C-suite executives will leave after the merger is finalized. Those executives are: Livongo CEO Zane Burke, President Jennifer Schneider, MD, CFO Lee Shapiro, and Senior Vice President of Business Development Steve Schwartz.
More articles on telehealth:
Telehealth one year from today: 4 CIO predictions
MedStar Health reduces certain ED visit lengths by nearly 63% via telehealth
Fitbit CEO hints at company’s telemedicine plans
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
